Search research articles
Contact Us
Filters
Showing results (21-30 of 124) with videos related to
Page
of 13
Sort By:
Anticancer Research
|
May 5, 1999
Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4+ cell proliferation
E Sara, A Kotsakis, J Souklakos, et al.
Angiogenesis
|
October 1, 2003
Neoplastic stroma and epithelium show up-regulation of platelet-derived endothelial cell growth factor/thymidine phosphorylase in colorectal carcinomas but not adenomas
L Kaklamanis, S Kakolyris, H Turley, et al.
Neoplasma
|
March 20, 2008
Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism
E Papadopoulou, K Anagnostopoulos, G Tripsianis, et al.
Oncology
|
June 18, 2002
Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors
D Mavroudis, Ch Kouroussis, S Kakolyris, et al.
Neoplasma
|
February 2, 2008
The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome
E Papadopoulou, G Tripsianis, K Anagnostopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2000
Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study
M I Koukourakis, G Kyrias, S Kakolyris, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 4, 2001
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy
S Kakolyris, J Souglakos, S Agelaki, et al.
Cancer Research
|
May 1, 1997
Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence
S Kakolyris, L Kaklamanis, K Engels, et al.
Acta Oncologica (Stockholm, Sweden)
|
June 20, 2000
High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas--rationale for combination with radiotherapy
M I Koukourakis, S Koukouraki, A Giatromanolaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2015
Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
D Mavroudis, E Saloustros, N Malamos, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 124) with videos related to
Sort By:
Page
of 13
Anticancer Research
|
May 5, 1999
Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4+ cell proliferation
E Sara, A Kotsakis, J Souklakos, et al.
Angiogenesis
|
October 1, 2003
Neoplastic stroma and epithelium show up-regulation of platelet-derived endothelial cell growth factor/thymidine phosphorylase in colorectal carcinomas but not adenomas
L Kaklamanis, S Kakolyris, H Turley, et al.
Neoplasma
|
March 20, 2008
Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism
E Papadopoulou, K Anagnostopoulos, G Tripsianis, et al.
Oncology
|
June 18, 2002
Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors
D Mavroudis, Ch Kouroussis, S Kakolyris, et al.
Neoplasma
|
February 2, 2008
The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome
E Papadopoulou, G Tripsianis, K Anagnostopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2000
Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study
M I Koukourakis, G Kyrias, S Kakolyris, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 4, 2001
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy
S Kakolyris, J Souglakos, S Agelaki, et al.
Cancer Research
|
May 1, 1997
Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence
S Kakolyris, L Kaklamanis, K Engels, et al.
Acta Oncologica (Stockholm, Sweden)
|
June 20, 2000
High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas--rationale for combination with radiotherapy
M I Koukourakis, S Koukouraki, A Giatromanolaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2015
Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
D Mavroudis, E Saloustros, N Malamos, et al.
Page
of 13